Cognetivity Neurosciences Ltd. (CGN.CN) Research

Cognetivity Neurosciences Ltd. operates as a healthcare firm, specializing in the development of an integrated cognitive assessment platform. This advanced testing system, applicable across medical, commercial, and consumer environments, is designed to identify the earliest indicators of cognitive impairment by evaluating the performance of broad brain regions, thereby aiding in the diagnosis of dementia. The company also offers OptiMind, a dedicated wellness application. Established in 2015, Cognetivity Neurosciences Ltd. maintains its headquarters in Vancouver, Canada. The organization was previously known as Utor Capital Corp. before adopting its current name in December 2017.

Market snapshot

Symbol
CGN.CN
Price
$0.01
Day change
0.00%
Market cap
$895.9K
P/E ratio
-0.13x
52-week range
0.01-0.045
Sector
Healthcare
Industry
Medical - Healthcare Information Services

Peer companies

  • Green Scientific Labs Holdings Inc. (GSL.CN)
  • Lotus Ventures Inc. (J.CN)
  • Medivolve Inc. (MEDV.NE)
  • Newtopia Inc. (NEWU.V)
  • Lumiera Health Inc. (NHP.V)
  • Enlighta Inc. (NLTA.V)
  • NeutriSci International Inc. (NU.V)
  • PsyBio Therapeutics Corp. (PSYB.V)

Open Cognetivity Neurosciences Ltd. (CGN.CN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.